Gland Pharma Ltd share price was down by -0.67% from the previous closing price of ₹1,634.00. Who are peers of Gland Pharma Ltd? The peers of Gland Pharma Ltd are Sun Pharmaceutical Industries ...

The German firm licensed a PRMT5 inhibitor that’s now in Phase 1 testing. Elsewhere, GSK is testing an intriguing hypothesis and Novo fine tuned its Wegovy cash-pay program.

Gland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 26,740.85 Crore) operating in Pharmaceuticals sector. Gland Pharma Ltd. key Products/Revenue ...

Blujepa, which treats UTIs in female patients aged 12 and up with common and uncomplicated infections, will hit the market in ...

Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends in the pharmaceutical sector.